A1C Drink, founded with the mission to revolutionize diabetic-friendly beverages, focuses on creating innovative drinks that cater to diabetics, pre-diabetics, and those with insulin resistance. Their flagship product, CINNABLAST, is a unique beverage designed to be safe for diabetics while offering a refreshing taste that appeals to a broader audience. The company operates primarily through e-commerce, targeting the American market of obese, overweight, and diabetic individuals.
Notable for its scientific foundation, A1C Drink's CINNABLAST is based on over 500 medical and scientific studies, making it a pioneering product in the health beverage industry. The company has garnered attention for its patent-pending organic compound and its potential to significantly impact the lives of those managing diabetes. While specific investors and affiliated people are not detailed, A1C Drink's achievements lie in its innovative approach and commitment to health-focused solutions.
